Analysts Split on Banks and Genomics

The most striking target price move today comes from ILMN. Canaccord Genuity lifted its target on Illumina to $300 from $205, a 46% jump. The analyst maintained a Hold rating, suggesting caution despite the bullish price revision.

EL caught a rare boost. Jefferies raised its target on Estee Lauder to $120 from $100. The Hold rating stays in place, but the 20% target lift signals growing confidence in the beauty giant's recovery.

Regional banks drew mixed calls. Stephens cut its target on RF to $30 from $32 while PNC saw Truist trim to $248 from $252. Both analysts held their ratings.

Energy services took a small hit. Piper Sandler cut targets on both SLB and HAL, each by $1. Both stocks kept Buy ratings. Equifax lost ground too, with Mizuho slashing its target to $185 from $210 while keeping a Buy.

On the positive side, TRV got a target bump to $435 from $425 at Truist. OXY edged up to $80 from $78 at Stephens. VRSN climbed to $351 from $341 at Wedbush.

The Illumina revision stands out. At 46%, it dwarfs every other move in today's batch, suggesting the analyst sees meaningful upside even while stopping short of a full Buy.